Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$65.68 USD
-0.49 (-0.74%)
Updated May 24, 2024 03:59 PM ET
After-Market: $65.47 -0.21 (-0.32%) 7:58 PM ET
5-Strong Sell of 5 5
B Value C Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | 1.59 |
EPS Last Quarter | -1.32 |
Last EPS Surprise | 11.41% |
ABR | 2.20 |
Earnings ESP
|
-1.29% |
---|---|
Current Year | 3.76 |
Next Year | 7.19 |
EPS (TTM) | 4.03 |
P/E (F1) | 17.49 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.70B | 6.96B | 27.54B | 27.96B |
# of Estimates | 10 | 10 | 10 | 10 |
High Estimate | 6.87B | 7.11B | 27.76B | 28.67B |
Low Estimate | 6.49B | 6.89B | 27.26B | 27.38B |
Year ago Sales | 6.60B | 7.05B | 27.12B | 27.54B |
Year over Year Growth Est. | 1.56% | -1.26% | 1.57% | 1.51% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.59 | 1.74 | 3.76 | 7.19 |
# of Estimates | 11 | 10 | 13 | 13 |
Most Recent Consensus | 1.49 | 1.75 | 3.71 | 7.15 |
High Estimate | 1.69 | 1.94 | 3.93 | 7.80 |
Low Estimate | 1.42 | 1.59 | 3.60 | 6.61 |
Year ago EPS | 1.34 | 2.29 | 6.72 | 3.76 |
Year over Year Growth Est. | 18.66% | -24.02% | -44.05% | 91.26% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 4 | 0 | 3 | 3 |
Up Last 60 Days | 1 | 1 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 4 | 7 | 8 | 7 |
Down Last 60 Days | 8 | 8 | 13 | 11 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.59 | 1.74 | 3.76 | 7.19 |
7 Days Ago | 1.59 | 1.74 | 3.76 | 7.19 |
30 Days Ago | 1.61 | 1.85 | 4.87 | 7.27 |
60 Days Ago | 1.66 | 1.91 | 7.09 | 7.50 |
90 Days Ago | 1.66 | 1.91 | 7.09 | 7.50 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.57 | 1.71 | 3.74 | 7.27 |
Zacks Consensus Estimate | 1.59 | 1.74 | 3.76 | 7.19 |
Earnings ESP | -1.29% | -1.61% | -0.30% | 1.12% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.32 | 1.72 | 2.29 | 1.34 | NA |
Estimate | -1.49 | 1.76 | 1.91 | 1.60 | NA |
Difference | 0.17 | -0.04 | 0.38 | -0.26 | 0.06 |
Surprise | 11.41% | -2.27% | 19.90% | -16.25% | 3.20% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more